Early Access — free while we kick the tires
EdgarHawk

Gero Deborah Ann

Director

Director
2 filings analyzed · 1 company · Latest 2026-03-18

Companies

Company Buys Sells Direction
Oaktree Specialty Lending Corp OCSL 2 0 Net buying

Activity

March 2026
Buy
2,000 shares
$21,558
Significance 4/10

Director Gero buys 2,000 shares of OCSL at $10.78; stock now at $11.26, down 28.6% from 52-week high

Director Deborah Ann Gero purchased 2,000 shares at $10.78 on 2026-03-16, increasing her holdings by 8.9% to 24,411 shares. The purchase occurred near the 52-week low ($10.78), with the stock currently trading at $11.26—still 28.6% below its 52-week high of $15.78 and down 12.2% over 90 days. Gero's prior buy at OCSL on 2025-06-30 resulted in a negative 90-day return (-4.7%), and her cross-ticker track record shows zero wins in limited transaction history (0.00% 90-day win rate). The timing coincides with price weakness rather than recovery momentum.

July 2025
Buy
2,500 shares
$34,250
Significance 3/10

Director Deborah Ann Gero buys 2,500 shares of OCSL at $13.70; holds 22,411 shares post-transaction.

Director Deborah Ann Gero purchased 2,500 shares at $13.70 on 2025-06-30, increasing her holdings to 22,411 shares—a 12.6% net increase from her prior position of 19,911 shares. The purchase occurred as the stock traded 26.9% below its 52-week high of $18.82 and had declined 10.2% over the prior 90 days. However, context for interpreting this buy is limited: the company reported net income of -$36,249,000.00 and has a P/E ratio of 137.50, indicating deep losses. Without visibility into whether this purchase was discretionary or scheduled under a trading plan, and without prior trading history to establish Gero's typical behavior, the isolated transaction provides insufficient signal regarding her conviction or the stock's outlook. The acquisition warrants attention primarily as a data point for tracking this director's ongoing commitment to the company.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access